Tumor endothelial cells also show reduced expression of leukocyte binding molecules, including ICAM-1 and 2, VCAM-1, E-selectin and CD34, leading to reduced response to inflammatory signals and defective recruitment of immune cells (28, 29). This evidence concerns the gene VCAM1 and neoplasm.